Molecular optical imaging: applications leading to the development of present day therapeutics
about
Fluorescent imaging of cancerous tissues for targeted surgery.An introduction to molecular imaging in radiation oncology: a report by the AAPM Working Group on Molecular Imaging in Radiation Oncology (WGMIR)Genetic engineered molecular imaging probes for applications in cell therapy: emphasis on MRI approachKey factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and developmentDynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe.A review of novel optical imaging strategies of the stroke pathology and stem cell therapy in strokeHuman IL-12 p40 as a reporter gene for high-throughput screening of engineered mouse embryonic stem cellsA biological global positioning system: considerations for tracking stem cell behaviors in the whole body.Stem cell transplantation in brain tumors: a new field for molecular imaging?ATP-binding cassette transporters modulate both coelenterazine- and D-luciferin-based bioluminescence imagingIn vivo imaging of HIF-active tumors by an oxygen-dependent degradation protein probe with an interchangeable labeling system.A phage-targeting strategy for the design of spatiotemporal drug delivery from grafted matricesMolecular imaging with bioluminescence and PET reveals viral oncolysis kinetics and tumor viability.A radiolabeled nonapeptide probe targeting PC-3 cells and bone metastases of prostate cancer in mice.Integrin targeting for tumor optical imagingTranslational molecular imaging for cancer.Systematic calibration of an integrated x-ray and optical tomography system for preclinical radiation research.Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL.The binding characteristics of a cyclic nonapeptide, c(CGRRAGGSC), in LNCaP human prostate cancer cells.Optical molecular imaging-guided radiation therapy part 2: Integrated x-ray and fluorescence molecular tomography.Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment.Quantified ultrasound elastography in the assessment of cutaneous carcinomaModern imaging technologies in toxicologic pathology: An overview.Characterization of differential Toll-like receptor responses below the optical diffraction limit.Inhibiting kinases in malignant gliomas.Magnetic and fluorescent nanoparticles for multimodality imaging.Persistent gammaherpesvirus replication and dynamic interaction with the host in vivo.In vivo quantifying molecular specificity of Cy5.5-labeled cyclic 9-mer peptide probe with dynamic fluorescence imaging.Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancerBioluminescence: a versatile technique for imaging cellular and molecular features.Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and TemozolomideOptical and multimodality molecular imaging: insights into atherosclerosis.Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction.Noninvasive cell-tracking methods.Preclinical imaging of the cellular and molecular events in the multistep process of bone metastasis.Solid silica nanoparticles: applications in molecular imaging.PEG conjugation of a near-infrared fluorescent probe for noninvasive dual imaging of lung deposition and gene expression by pulmonary gene delivery.Glucosamine-linked near-infrared fluorescent probes for imaging of solid tumor xenograftsOptical Imaging of Bacterial Infection ModelsHapten-derivatized nanoparticle targeting and imaging of gene expression by multimodality imaging systems.
P2860
Q26830905-F1953326-C451-49A3-BD07-E608284367B4Q27002845-04D8721D-D6DF-46C3-872D-CAA81104D01FQ28078109-05C4EC1F-47A2-4A1D-8CC3-A546F768CAC9Q28082880-FAB7FAA9-CE16-442B-8DF7-067110322822Q30524330-1D460671-10DF-4490-B6F8-27E82814E6E6Q30846905-E4F77FCB-059F-4B0D-8FFB-5865241646B7Q33340168-EAD81DCA-E168-4D58-8D2E-859676C524F2Q33541898-B9EA591E-663F-4F5A-BD35-99F2E633CB9DQ33622514-EDA7529E-D6AF-4050-ABAC-AD96894E12ACQ33738298-ADD695FE-E8C6-4800-9EB1-D910C890973EQ33784382-AECBD5DE-2A47-4198-A964-107B63AE78CFQ33823155-32776B95-6840-48D3-90E3-94BA36F5A5AFQ34099721-47F08C79-BD42-4421-8941-7B0FD3495577Q34204255-109C4780-786D-45B3-9C83-BC9C6675528FQ34912662-BF2078A1-C002-492B-BFD5-CF9F101593BAQ35173093-B73392C5-E4B6-4A0C-AD69-425A57835757Q35202763-AB33BA62-B813-4C8C-BAB9-353F76823C68Q35812718-9D32827E-572C-4526-B505-7B42330B30CDQ36226131-95A103CA-25FD-48D3-AD83-05DCA989A6ABQ36408697-D1411BD7-F1F8-4DF2-887F-1FD7DF2B846EQ36499234-8FCF1C88-3BAF-4933-B969-6A3EC82AEBA0Q36514503-3EA23321-F953-4368-B139-02D85BBC0955Q36687999-94FFB48D-87A6-4C1F-BD50-ECAEB5C6F234Q36733678-2A992EC2-FE3B-4B2B-84FF-C94C4DB955F0Q36764876-83DBBE5D-2BF0-4B16-8FC4-296497FFDD0AQ36918024-6D78597E-0C7E-4DAB-8727-2B2A60EFC590Q36994671-E437D7DC-A27D-4A37-9329-54484FF0711CQ37057575-47CD8223-7748-472E-95A0-7762A914CE5EQ37139112-AB5B8053-2399-4D76-BCC0-23E920F563A6Q37221749-C239E480-FD1C-46B3-90FE-EB69C1115587Q37356520-53DD276A-E86C-42B3-BBA8-CF077E8F314AQ37440343-EAA8DA17-4032-4CC8-87D7-6B5C3FE33547Q37657516-279944FC-35CE-4F84-B396-BECB060BEEB8Q37938642-5B91BC1B-F61F-4267-88FA-1EE77DA63362Q38003667-FA157633-BD4C-44DD-9034-967B55ABB93BQ38226377-17840AF8-40F7-4948-B343-ACFA6CC1AFAAQ39272165-5F85A662-627C-42F8-AFD1-6A99423F2380Q39463185-EA72DF84-7AE5-478E-A6A7-9BDE3181551BQ39888990-98819880-3E28-411F-83C3-86530902E4F9Q39938196-3374B57D-1FD8-4075-A158-8CB42364205D
P2860
Molecular optical imaging: applications leading to the development of present day therapeutics
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Molecular optical imaging: app ...... nt of present day therapeutics
@ast
Molecular optical imaging: app ...... nt of present day therapeutics
@en
type
label
Molecular optical imaging: app ...... nt of present day therapeutics
@ast
Molecular optical imaging: app ...... nt of present day therapeutics
@en
prefLabel
Molecular optical imaging: app ...... nt of present day therapeutics
@ast
Molecular optical imaging: app ...... nt of present day therapeutics
@en
P2860
P356
P1433
P1476
Molecular optical imaging: app ...... nt of present day therapeutics
@en
P2093
Khalid Shah
P2860
P304
P356
10.1602/NEURORX.2.2.215
P577
2005-04-01T00:00:00Z